Kinovate
Pre-clinicalSince inception in 2004, Kinovate has grown to become the market leader in high performance, high quality polymeric solid support for the synthesis of therapeutic oligonucleotide market. NittoPhase™ and NittoPhase™ HL are loaded with all canonical nucleobase as well as modified bases, linkers and custom ligands at a wide range of loading suitable to every project from 40 to 400 µmol/g and anywhere in between. Kinovate’s products are manufactured under “Quality System Management” compliant wit...
About
Since inception in 2004, Kinovate has grown to become the market leader in high performance, high quality polymeric solid support for the synthesis of therapeutic oligonucleotide market. NittoPhase™ and NittoPhase™ HL are loaded with all canonical nucleobase as well as modified bases, linkers and custom ligands at a wide range of loading suitable to every project from 40 to 400 µmol/g and anywhere in between. Kinovate’s products are manufactured under “Quality System Management” compliant wit...
Company Info
Contact
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile